Jake

Ypke van Oosterhout, PhD | Executive Director

Ypke van Oosterhout (1964) is the pioneering scientist/researcher behind T-Guard’s development, and the founder and CEO of Xenikos. His in-depth knowledge, hands-on experience and proven commitment to development of the medicine are unparalleled. After receiving his Masters Degree in Biology from the University of Nijmegen (the Netherlands), Ypke worked as a researcher...

Read more ...

Jon

Jon Edwards, PhD | Non-executive Director

Jon Edwards is a Principal in the investment team at Medicxi, with a main focus on early-stage opportunities. Prior to Medicxi, Jon worked at Index as an Associate for two years. Before that, he worked as a life science strategy consultant at ClearView Healthcare Partners.
Next to being a boardmember at Xenikos, Jon is also on the boards of Palladio Biosciences...

Read more ...

Jake

Jake Simson, PhD | Non-executive Director

Jake Simson is a Principal on the Investment Team  at RA Capital Management, where his primary responsibility is to conduct due diligence on biotechnology companies. Prior to this role, Jake was a Senior Associate on the Landscape Team within the TechAtlas division of RA Capital, where he mapped competitive landscapes in the solid tumor oncology space and...

Read more ...